China Pharma Holdings (CPHI) EBT Margin Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 | -10,225.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,709.00 |
| Dec 31, 2025 | 829.00 |
| Sep 30, 2025 | 1,546.00 |
| Jun 30, 2025 | 10,397.00 |
| Mar 31, 2025 | 65.00 |
| Dec 31, 2024 | -5,065.00 |
| Sep 30, 2024 | -5,850.00 |
| Jun 30, 2024 | -10,147.00 |
| Mar 31, 2024 | -4,550.00 |
| Dec 31, 2023 | -1,404.00 |
| Sep 30, 2023 | -289.00 |
| Jun 30, 2023 | 106.00 |
| Mar 31, 2023 | 3,990.00 |
| Dec 31, 2022 | -934.00 |
| Sep 30, 2022 | 156.00 |
| Jun 30, 2022 | -2,093.00 |
| Mar 31, 2022 | -3,165.00 |
| Dec 31, 2021 | 731.00 |
| Sep 30, 2021 | 29.00 |
| Jun 30, 2021 | -3,449.00 |